Drugs / SSR150106
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00545454 | Oct 2007 → Jun 2008 | rheumatoid arthritis | Sanofi | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SSR150106 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00545454 ↗ |
| Known as | SSR-150106XB | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297498 ↗ |
| Modality | Small molecule | — CHEMBL4297498 ↗ |
| Route | Oral | “90 micro grams oral solution once daily (QD)” NCT00545454 ↗ |